Biography:
Based in Sheffield, David is a Partner in Irwin Mitchell’s Personal Injury Department, He Chairs
the Medical Law Executive, as Head of the National Clinical Negligence and Medical Law &
Patients’ Rights team. He manages the firm’s Sheffield Clinical Negligence Team, day to day.
David’s specialist area of practice is clinical negligence and product liability on behalf of
claimants. He acted for the Claimant(s) in
•
Maynard v West Midlands RHA,
•
Aboul-Hosn v Governors of National Hospital for Nervous Diseases,
•
Bolitho v City and Hackney Health Authority,
•
Fisher v North Derbyshire Health Authority and in the
•
Creutzfeldt - Jakob Disease Litigation.
He represented the variant CJD victims’ families at the BSE Inquiry 1998-2000, 2000-01
negotiated the terms of the vCJD Trust (the no fault compensation scheme for vCJD claims) and
implemented the terms of that scheme. He also represented the families in Treatment Decision
applications in relation to experimental drug therapy for Jonathan Simms, HM, EP and HC.
He was lead Claimants solicitor in the Fetal Anti-Convulsant Litigation 2002- 2010
Currently, David is a member of the Steering Committees for both the PiP Litigation and the De
Puy ASR claims
David lectures regularly to both doctors and lawyers and is a member of APIL and a senior
litigator in CPIL, AvMA, ATLA (ATLA Birth Trauma Litigation Group).He is also a Member of
and Assessor for the SRA’s Clinical Negligence Panel
David is a Trustee of both the Patients’ Association and the Degenerative Encephalopathy
Research Group.
He has recently retired from membership of the Warwick Medical School Supervisory Group
He is the author of chapters on ‘Creutzfeldt-Jakob Disease Litigation for ‘’Multi-party Actions’
(Ed. Christopher Hodges) OUP. He also wrote ‘Redress for CJD’ (with Jonathan Glasson) for
‘Clinical Risk’ January 2005.He has most recently written an article for JPIL on ‘Practical
problems with Claims under the Product Liability Directive’ and the submission on behalf of the
Claimant Product Liability Solicitors’ Group for the Keogh review of cosmetic interventions’’
Based in Sheffield, David is a Partner in Irwin Mitchell’s Personal Injury Department. He
Chairs the Medical Law Executive, which runs Irwin Mitchell’s Medical Law & Patients’ Rights
team . He manages the firm’s Sheffield Clinical Negligence Team, day to day.
. David’s specialist area of practice is in clinical negligence and product liability
on behalf of claimants.
He acted for the Claimant(s)in
·
Maynard v West Midlands RHA,
·
Aboul-Hosn v Governors of National Hospital for Nervous Diseases,
·
Bolitho v City and Hackney Health Authority,
·
Fisher v North Derbyshire Health Authority and in the
·
Creutzfeldt - Jakob Disease Litigation.
He represented the variant CJD victims’ families at the BSE Inquiry 1998-2000, In 2000-01
he negotiated the terms of the vCJD Trust (the no fault compensation scheme for vCJD claims)
and implemented the terms of that scheme 2002-6. He also represented the families in Treatment
Decision applications in relation to experimental drug therapy for Jonathan Simms, HM, EP and
HC.
He was lead Claimants solicitor in the Fetal Anti-Convulsant Litigation.2002- 2010
Currently, David is a member of the Steering Committees for both the PiP Litigation and the De
Puy ASR claims
David lectures regularly to both doctors and lawyers and is a member of APIL, AvMAand of the
AAJ
.He is also a Member of and Assessor for the SRA’s Clinical Negligence Panel
David is a Trustee of both the Patients’ Association and the Degenerative Encephalopathy
Research Group.He has recently retired from membership of the Warwick Medical School
Supervisory Group
He is the author of chapters on ‘Creutzfeldt-Jakob Disease Litigation for ‘’Multi-party Actions’
(Ed. Christopher Hodges) OUP. He also wrote ‘Redress for CJD’ (with Jonathan Glasson) for
‘Clinical Risk’ January 2005.He has most recently written an article for JPIL on ‘Practical
problems with Claims under the Product Liability Directive’ and the submission on behalf of the
Claimant Product Liability Solicitors’ Group for the Keogh review of cosmetic interventions’’